• Han Khim Tan, Manish Kaushik, Chee Wooi Tan, Zhong Hong Liew, Su Hooi Teo, Chian Min Loo, Li Choo Ng, Lina Hui Lin Choong, and Marjorie Wai Yin Foo.
• Department of Renal Medicine, Singapore General Hospital, Singhealth-Duke Academic Medical Centre, Singapore, Singapore, tan.han.khim@singhealth.com.sg.
• Blood Purif. 2019 Jan 1; 47 Suppl 3: 1-6.

AbstractThe use of the oXiris® haemofilter during continuous veno-venous haemodiafiltration (CVVHDF) for acute kidney injury (AKI) and severe sepsis is not completely understood. Although this filter has in vitro adsorptive properties for blood-borne cytokines and other humoural mediators of sepsis, its clinical usefulness is uncertain. Given its inherent adsorptive limitation for septic mediators, we developed a CVVHDF protocol in which the oXiris haemofilter was electively changed every 12 h even though there was no clotting or adverse circuit pressures. Augmented filter membrane adsorption was conducted for 3 consecutive days. We treated a critically ill patient with severe sepsis secondary to a gram-negative bacterial infection and sepsis-associated acute kidney injury (SA- AKI) in this way. The patient required high-dose vasopressor support, required mechanical ventilation, had received 12 h of CVVHDF with conventional M100 haemofilter, was on broad spectrum antibiotics and other conventional intensive care unit (ICU) care, prior to institution of the frequent oXiris haemofilter change protocol. Following the start of elective 12 hourly oXiris filter change, the patient showed reduction in the need for vasopressor and by Day 4 of this SA- AKI frequent filter change protocol, vasopressor requirement ceased, he was extubated. He survived ICU and but not hospital stay. To this end, more clinical studies are needed.© 2019 The Author(s). Published by S. Karger AG, Basel.

16 keywords...

hide…